WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that the Company’s President and Chief Executive Officer, Noah D. Beerman, will present a corporate overview at the 6th Annual Rodman & Renshaw Global Healthcare Conference, on Tuesday, May 18, 2010 at 9:00 am BST (4:00am EDT) at the Grosvenor House Hotel, London, UK.
